PMC:7029759 / 35931-36140 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T675","span":{"begin":141,"end":155},"obj":"BV_15"},{"id":"T674","span":{"begin":157,"end":164},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T673","span":{"begin":179,"end":187},"obj":"CHEBI:60809;CHEBI:60809"}],"text":" and specifically, the RBD protein. Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent "}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T225","span":{"begin":27,"end":34},"obj":"Body_part"}],"attributes":[{"id":"A225","pred":"fma_id","subj":"T225","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":" and specifically, the RBD protein. Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T157","span":{"begin":27,"end":34},"obj":"Chemical"},{"id":"T158","span":{"begin":157,"end":164},"obj":"Chemical"},{"id":"T159","span":{"begin":179,"end":187},"obj":"Chemical"}],"attributes":[{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A158","pred":"chebi_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A159","pred":"chebi_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":" and specifically, the RBD protein. Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent "}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":157,"end":177},"obj":"http://purl.obolibrary.org/obo/GO_0019882"}],"text":" and specifically, the RBD protein. Such trials should happen as soon as possible, but may prove to be challenging to get the right level of immunogenicity, antigen presentation, adjuvant addition, and potent "}